RecruitingNot applicableNCT06650553

Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment Study

Studying Aplastic Anemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Shanxi Bethune Hospital
Principal Investigator
Tao Wang, Dr.
Shanxi Bethune Hospital Regulatory Authority
Intervention
Clinically diagnosed AA patients are divided into HLA-matched HSCT group and umbilical cord blood-supported haplo-HSCT group.(procedure)
Enrollment
110 enrolled
Eligibility
6-75 years · All sexes
Timeline
2024 – 2027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06650553 on ClinicalTrials.gov

Other trials for Aplastic Anemia

Additional recruiting or active studies for the same condition.

See all trials for Aplastic Anemia →

← Back to all trials